Posterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms.
Depressive symptoms occurring late in life are an important risk factor for Alzheimer's disease (AD). The latest research finds that onset of depressive symptoms in late life may herald the development of AD, not only for amnestic Mild Cognitive Impairment (aMCI) patients, but also for cognitively-normal older adults. Neuroimaging of brain structure, blood flow, and glucose metabolism indicates that depressive symptoms in late life are accompanied by structural and functional changes in limbic brain regions vulnerable to AD. The present cross-sectional study was guided by the hypothesis that compared to their non-depressed counterparts, older adults with mild to moderate depressive symptoms have less volume in limbic structures vulnerable to changes in AD-specifically, cortical midline structures such as anterior cingulate and posterior cingulate cortex as well as mesial temporal regions such as bilateral hippocampi and amygdalae. Consistent with our hypothesis, results of a voxel-based morphometry analysis revealed smaller retrosplenial, posterior cingulate, and precuneus gray matter volumes in depressed individuals relative to healthy controls. Right lateral parietal cortex-another region vulnerable to change in AD-was also smaller in the group with depressive symptoms. Contrary to our hypothesis, no volumetric differences were found in the anterior cingulate cortex or mesial temporal lobe. Results of this study show a relationship between geriatric depressive symptoms and brain volume in regions vulnerable to AD. Follow-up of participants over time will tell if brain changes detected here predict development of AD.
Ries
Michele L
ML
Wichmann
Allison
A
Bendlin
Barbara B
BB
Johnson
Sterling C
SC
Int J Geriatr Psychiatry. 2001 Jul;16(7):718-27
11466752
Am J Psychiatry. 2002 Aug;159(8):1424-7
12153839
Dement Geriatr Cogn Disord. 2006;21(1):44-50
16254430
Psychol Med. 1992 Aug;22(3):607-15
1410086
Biol Psychiatry. 2000 Aug 15;48(4):301-9
10960161
Neuron. 2004 Sep 30;44(1):195-208
15450170
J Geriatr Psychiatry Neurol. 2005 Dec;18(4):245-9
16306248
Arch Neurol. 2004 Aug;61(8):1290-3
15313849
Neuroimage. 2006 Jan 15;29(2):452-66
16140550
Lancet. 2005 Jun 4-10;365(9475):1961-70
15936426
Ann N Y Acad Sci. 1999 Jun 29;877:614-37
10415674
Int J Geriatr Psychiatry. 2007 Jun;22(6):536-42
17096467
J Alzheimers Dis. 2005 Mar;8(4):347-58
16556966
J Neurosci. 2006 May 31;26(22):6069-76
16738250
Psychol Med. 1999 May;29(3):629-38
10405084
Br J Psychiatry. 2005 Mar;186:197-202
15738499
J Neurosci. 2004 Nov 10;24(45):10084-92
15537877
Arch Neurol. 2006 May;63(5):693-9
16682538
Brain. 2002 Aug;125(Pt 8):1808-14
12135971
Psychol Med. 1997 Mar;27(2):421-31
9089834
Arch Gen Psychiatry. 2008 May;65(5):542-50
18458206
Neuroimage. 2001 Jul;14(1 Pt 1):21-36
11525331
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82
11209064
Neuroimaging Clin N Am. 2005 Nov;15(4):869-77, xi-xii
16443497
Alzheimers Dement. 2006 Oct;2(4):296-302
19020671
Dement Geriatr Cogn Disord. 2008;25(2):115-26
18087152
Am J Psychiatry. 2004 Jan;161(1):99-108
14702257
Neuroimage. 2006 May 15;31(1):440-57
16466680
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):253-8
12506194
Am J Psychiatry. 2008 Feb;165(2):229-37
17986679
J Comp Neurol. 2000 May 22;421(1):14-28
10813770
Am J Geriatr Psychiatry. 2008 Feb;16(2):168-74
18239198
Arch Neurol. 2006 Mar;63(3):435-40
16533972
Am J Alzheimers Dis Other Demen. 2008 Aug-Sep;23(4):326-33
18453641
Int J Geriatr Psychiatry. 2008 Apr;23(4):347-55
17979214
Nature. 1997 Apr 24;386(6627):824-7
9126739